The Effect of Rituximab on the Development of Anti-Donor Antibodies
This study has been completed.
Sponsor:
University of California, San Francisco
Collaborator:
Genentech
Information provided by:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00695097
First received: June 9, 2008
Last updated: July 6, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |